Principal Investigator
Macarena De La Fuente
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20180900
Clinical Trial Summary
Compassionate Access to Dabrafenib and Trametinib for the Treatment of a patient with Histiocytosis with BRAF V600E Mutant Including CNS Lesions
Phase
N/A
Funding Agency/Sponsor
Institutional
Disease
Neurological Cancer
Contact Information
Phone Number
+1 (305) 2431194